Strs Ohio boosted its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 4.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 410,500 shares of the exchange traded fund’s stock after purchasing an additional 19,300 shares during the period. Strs Ohio’s holdings in SPDR S&P Biotech ETF were worth $52,433,000 at the end of the most recent quarter.
A number of other large investors have also recently modified their holdings of the business. Financial Life Planners acquired a new position in shares of SPDR S&P Biotech ETF during the 1st quarter worth $27,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new stake in SPDR S&P Biotech ETF in the fourth quarter valued at about $27,000. Intesa Sanpaolo Wealth Management bought a new position in SPDR S&P Biotech ETF in the fourth quarter valued at about $30,000. SHP Wealth Management bought a new position in SPDR S&P Biotech ETF in the fourth quarter valued at about $31,000. Finally, Legacy Wealth Managment LLC ID acquired a new position in SPDR S&P Biotech ETF during the fourth quarter worth about $32,000.
SPDR S&P Biotech ETF Trading Up 2.5%
Shares of NYSEARCA XBI opened at $160.46 on Friday. The company has a market cap of $11.09 billion, a price-to-earnings ratio of 11.47 and a beta of 0.81. SPDR S&P Biotech ETF has a 12 month low of $83.02 and a 12 month high of $160.82. The stock has a 50-day moving average price of $136.95 and a two-hundred day moving average price of $129.75.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Featured Articles
- Five stocks we like better than SPDR S&P Biotech ETF
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
